title: Part 1: MRI features of focal nodular hyperplasia with an emphasis on hepatobiliary contrast agents.
abstract: Focal nodular hyperplasia (FNH) is the second most common benign liver tumour and typically do not require any treatment. An accurate non-invasive diagnosis is therefore vital to avoid unnecessary intervention and to reassure patients. This article discusses the demographics and pathology of FNH and reviews the appearance of FNH at MRI using liver-specific contrast agents.
authors.affiliation: Medical Imaging Department, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
authors.forename: Tom
authors.initials: T
authors.lastname: Sutherland
authors.forename: Melanie
authors.initials: M
authors.lastname: Seale
authors.forename: Kelvin
authors.initials: K
authors.lastname: Yap
mesh_terms: D001652:Bile Ducts / Q000473:pathology*; D002614:Chelating Agents; D003287:Contrast Media; D020518:Focal Nodular Hyperplasia / Q000473:pathology*; D005682:Gadolinium; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D008099:Liver / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D002614:Chelating Agents; D003287:Contrast Media; D005682:Gadolinium
keywords: MRI; abdomen; hepatobiliary imaging